Opinion
Video
Author(s):
The expert panel provides comprehensive insights on another patient case, a 77-year-old with MDS who presented with symptomatic anemia.
Asciminib Bests Standard-of-Care TKIs in Ph+ CML
Levy Lends Insights Into the Current and Future Use of ADCs in NSCLC
Vanderbilt Symposium Highlights Recent Data on Novel Agents Under Evaluation in Hematologic Malignancies
Revisit the OncLive On Air Episodes From February 2024
CAR T-Cell Therapies Move Ahead in Pediatric and Adult ALL
WU-CART-007 Receives FDA RMAT and EMA PRIME Designations for R/R T-ALL and T-LBL
Lorlatinib Yields Longest Reported PFS in Advanced NSCLC
Rivoceranib Plus Camrelizumab Maintains Frontline Survival Benefit in Unresectable HCC
Dr Pal Previews ASCO 2024 Data in Renal Cell Carcinoma
Prospective Data Reveal Most Young Survivors of Breast Cancer Could Successfully Give Birth